Verdad Advisers »

Black Diamond Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $234k 96k 2.43

More positions owned by Verdad Advisers

Citigroup Com New (C)
TJX Companies (TJX)
Johnson & Johnson (JNJ)
Comcast Corp Cl A (CMCSA)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl A (GOOGL)
Lam Research Corp Com New (LRCX)
Tegna (TGNA)
Cisco Systems (CSCO)
Micron Technology (MU)
Voya Financial (VOYA)
Cbre Group Cl A (CBRE)
Zoom Communications Cl A (ZM)
At&t (T)
Bank of New York Mellon Corporation (BK)

View all positions for Verdad Advisers

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Vanguard Group
Acadian Asset Management
Marshall Wace
Siren
Arrowstreet Capital, Limited Partnership
Jane Street
Renaissance Technologies
BlackRock
Vestal Point Capital
Dimensional Fund Advisors
Millennium Management
Connor, Clark & Lunn Investment Management
AWM Investment Company

View all funds holding Black Diamond Therapeutics